StockStory.org on MSN
10x Genomics (NASDAQ:TXG) delivers impressive Q4 CY2025
Biotech company 10x Genomics (NASDAQ:TXG) reported in Q4 CY2025, but sales were flat year on year at $166 million. The ...
10x Genomics (NASDAQ: TXG) released its Q4 earnings on Thursday, February 12, 2026 at 04:05 PM. Here's what's important from the earnings announcement. 10x Genomics missed estimated earnings by -30.0% ...
10x Genomics has experienced a significant decline in share price, currently trading around $20 per share, with no bullish indicators for a potential reversal. Recent performance shows growth in total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results